Rajeev Saggar sold $1.9M of Liquidia (LQDA)

Executed Nov 5 2025, disclosed Nov 7 2025, 2 days later.

Value, as filed

$1.9M

71,381 sh across 2 lots

Executed

Nov 5 2025

the trade date, as filed

Disclosed

Nov 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RS Rajeev Saggar Chief Medical Officer profile →

Rajeev Saggar (Chief Medical Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $6.0M of LQDA (79,534 sh across 2 lots, as filed), executed Aug 17.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Rajeev Saggar in LQDA

LQDASALE Liquidia Corporation $6.0M
79,534 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 6:21 PM ET LQDASALE Liquidia Corporation $660K
9,223 sh × $71.52
Exec Jul 13
Filed Jul 14 · 8:02 PM ET LQDASALE Liquidia Corporation $354K
9,220 sh × $38.37
Exec Apr 13
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation $1.3M
35,365 sh × $36.30
Exec Mar 13
Filed Mar 17 · 5:30 PM ET LQDASALE Liquidia Corporation $791K
21,142 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET LQDASALE Liquidia Corporation $125K
5,327 sh × $23.41
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $557K
20,000 sh × $27.85
Exec Aug 28 2025
Filed Sep 2 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $129K
7,597 sh × $16.97
Exec Jun 4 2025
Filed Jun 5 2025 · 5:30 PM ET